{"id":2720,"date":"2022-01-21T21:29:42","date_gmt":"2022-01-21T21:29:42","guid":{"rendered":"https:\/\/blogs.sld.cu\/inmuno\/?p=2720"},"modified":"2022-01-21T21:29:42","modified_gmt":"2022-01-21T21:29:42","slug":"harnessing-antitumor-cd4-t-cells-for-cancer-immunotherapy","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/inmuno\/2022\/01\/21\/harnessing-antitumor-cd4-t-cells-for-cancer-immunotherapy\/","title":{"rendered":"Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy"},"content":{"rendered":"<p><a href=\"https:\/\/www.mdpi.com\/2072-6694\/14\/1\/260\/htm\">Cancers 2022;14(1):260<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancers 2022;14(1):260.<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[9,22,45],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts\/2720"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/comments?post=2720"}],"version-history":[{"count":1,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts\/2720\/revisions"}],"predecessor-version":[{"id":2721,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/posts\/2720\/revisions\/2721"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/media?parent=2720"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/categories?post=2720"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/inmuno\/wp-json\/wp\/v2\/tags?post=2720"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}